Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm® 12/2017
previous issue next issue
This is a translation of the table of contents. One article is translated and freely available.

SPOT ON
SPRINT study on more intensive blood pressure treatment significant questions still unsolved, first guidelines modified
ORBITA trial last nail in the coffin for PCI in stable angina?

NEW ON THE MARKET
Cladribine (MAVENCLAD) for multiple sclerosis

BEWARE MISINFORMATION
VIRUPROTECT and ALGOVIR against colds?

IN BRIEF
No pain medication against uncomplicated cystitis
Once again: teriparatide (FORSTEO) against osteoporosis

CURRENT ADR NETWORK REPORT
Ethinyl estradiol + dienogest (VALETTE, generics) frequently prescribed despite unclear risk of thromboembolism

SIDE EFFECTS
Anaphylaxis with iron isomaltoside (MONOFER)
Hypersexuality with donepezil (ARICEPT, generics)  free article 
Fatal arrhythmia and other adverse effects with fingolimod (GILENYA)

e a-t ON THE INTERNET
Particularly drugs with a small or no additional benefit are advertised
Libido pill flibanserin (USA: ADDYI) a billion dollar flop
© 2020 arznei-telegramm